Current Prices from ENLIVEX THERAPEUTICSCS LTDNARY SHARES

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ENLV	USD	13.06.2025 20:06	0,93 USD	0,94 USD -0,59 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-0,59 %	-3,66 %	-7,93 %	-22,12 %	-22,12 %	-32,77 %	-82,82 %

Company Profile for ENLIVEX THERAPEUTICSCS LTDNARY SHARES Share

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Company Data

Name ENLIVEX THERAPEUTICSCS LTDNARY SHARES

Company Enlivex Therapeutics Ltd.

Symbol ENLV

Website https://www.enlivex.com

Primary Exchange

NASDAQ CAPITAL MARKET

WKN A119KH

ISIN IL0011319527

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. Oren Hershkovitz Ph.D.

Market Capitalization 19 Mio

Country Israel

Currency USD

Employees 0,1 T

Address 14 Einstein Street, 7403618 Ness Ziona

IPO Date 2014-07-31

Stock Splits

Date	Split
06.03.2019	1:8
25.09.2017	1:5

ID Changes

Date	From	To
27.03.2019	ORPN	ENLV

Ticker Symbols

Name	Symbol
Frankfurt	1BT.F
NASDAQ	ENLV

More Shares

Investors who ENLIVEX THERAPEUTICSCS LTDNARY SHARES hold also have the following shares in their portfolio:

INVESTEC BANK PLC EUR IMPALA KO NTS CAR 19/06/23 Bond

Tempus AI, Inc. - Class A Common Stock Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog